You are here

The Progress Report Progress never stops. Stay informed with the latest news on breast cancer research, treatment, and prevention.


ASCO 2017 x

HER2-positive breast cancer

Once a disease with poor prognosis, HER2-positive breast cancer is now a very treatable breast cancer. In early stage HER2 breast cancer, the challenge facing clinicians is selecting the most efficacious therapy from the many options available.

Each year in early June the American Society of Clinical Oncology (ASCO) hosts the largest cancer conference in the world.